Update from the Annual General Meeting 2016

The annual general meeting in BioArctic Neuroscience AB was held on June 22, 2016.

Change of the company name

At the annual general meeting it was decided that the company name will be changed from BioArctic Neuroscience AB to BioArctic AB. The name change was effective July 14, 2016.

Election of the Board of Directors

Pär Gellerfors, Hans Ekelund, Ivar Verner and Mikael Smedeby were re-elected as ordinary board members. Wenche Rolfsen was elected as a new board member. Lars Lannfelt was re-elected as chairman of the board.

Presentation of Wenche Rolfsen

Wenche Rolfsen, Associate Professor, has extensive senior experience from the Swedish and international pharmaceutical industry and has held several leading positions at Pharmacia&Upjohn and Quintiles. Presently chairman of the board of Index Pharmaceuticals and board member of Swedish Match, Moberg Pharma, Industrifonden, Smartfish and BioArctic.

More information

For more information, please contact Lars Lannfelt, lars.lannfelt@bioarctic.se